Replies to post #141715 on Vivos Inc (RDGL)

[dekeferrell]

It's people who held this stock when it was under completely different [poor] management and a different name/symbol. >early 2017. Advanced Medical Isotopes ADMD. I got in at the tail end of ADMD and Dr. K became the CEO and the name changed to RDGL and I can say it's been great, slow but great.

[SC8]

No back story. Risks are quite visible. Yes company has much potential but to answer your questions:
Radiogel is another potential tool against solid tumors. It isn't going to defeat cancer by itself.
All longs want RDGL to be successful, but there are some obvious headwinds:
Management has fallen short vs. at least two forecasts this year.
Current offering appears dead in water. If RDGL doesn't have sufficient cash on hand to reach IDE approval (at which point raising more funds shouldn't be an issue), we're in deep merde and back to risk of bankruptcy like last year.
Nobody really knows what RDGL is worth without positive human clinical data, and that could be years off. Many may not wish to tie up funds that long on something this risky.
There is risk of another breakthrough approach, like immunotherapy making Radiogel obsolete before it can even reach market.
I'm sure others could list more reasons why we're at about a dime.

[WALLnut]

Jim Katzaroff was a con and crook and he fked over a lot of people back in 2015. Some lost a chit ton of money after Jim pumped up the pps and then sold out knowing the fda had given them a denial for a de novo.





RDGL